Herbert Haack
18Patents
5h-index
16Co-inventors
59Inventor score
Filing activity: Apr 2, 2007 → Nov 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7700339B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 6 | Active |
| US8377642B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 5 | Active |
| US8481279B2 | Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase | Emerging Cross-Sectional Technologies | 5 | Active |
| US8288102B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 5 | Active |
| US8168383B2 | Gene defects and mutant ALK kinase in human solid tumors | Emerging Cross-Sectional Technologies | 5 | Active |
| US8232060B2 | Gene defects and mutant ALK kinase in human solid tumors | Physics | 5 | Active |
| US8486645B2 | Gene defects and mutant ALK kinase in human solid tumors | Emerging Cross-Sectional Technologies | 2 | Active |
| US10551383B2 | Methods of detecting a polypeptide having anaplastic lymphoma kinase activity in kidney cancer | Physics | 1 | Active |
| US9988688B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 1 | Active |
| US7833736B2 | Protein markers of responsiveness to type III receptor tyrosine kinase inhibitors | Physics | 1 | Active |
| US11505833B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 0 | Active |
| US9539254B2 | Mutant ROS expression in human cancer | Physics | 0 | Active |
| US9523130B2 | Methods of treating non-small cell lung carcinoma (NSCLC) | Physics | 0 | Active |
| US10955416B2 | Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US10000568B2 | Compositions and methods for detecting EGFR in cancer | Physics | 0 | Active |
| US9364477B2 | Mutant ROS expression in human cancer | Physics | 0 | Active |
| US11099188B2 | ROS kinase in lung cancer | Physics | 0 | Active |
| US10870892B2 | Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.